Scientific Industries Inc has 5 Schedule 13D or 13G filings on record since 2025-08-13. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Bleichroeder LP | 21.19% | 2,715,026 | SCHEDULE 13D/A, 2025-11-14 | 2025-09-30 |
| North Run Capital, LP | 9.99% | 1,189,632 | SCHEDULE 13G/A, 2025-11-13 | 2025-09-30 |
| Lytton Laurence W | 9.99% | 1,226,104 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 |
| Pessin Sandra F | 4.7% | 466,507 | SCHEDULE 13D/A, 2025-08-22 | 2025-08-21 |
Purpose of Transaction (Item 4)
Pessin Sandra F
The Reporting Persons originally purchased the Shares based on the belief that the Shares, when purchased, were undervalued and represented an attractive investment opportunity. Depending upon overall market conditions, other investment opportunities available to the Reporting Persons, and the availability of Shares at prices that would make the purchase or sale of Shares desirable, the Reporting Persons may endeavor to increase or decrease their position in the Issuer through, among other things, the purchase or sale of Shares on the open market or in private transactions or otherwise, on such terms and at such times as the Reporting Persons may deem advisable. The Reporting Persons intend to review their investment in the Issuer on a continuing basis. Depending on various factors including, without limitation, the Issuer's financial position and investment strategy, the price levels of the Shares, conditions in the securities markets and general economic and industry conditions, the Reporting Persons may in the future take such actions with respect to their investment in the Issuer as they deem appropriate including, without limitation, communications with management and the Board of Directors of the Issuer, engaging in discussions with third parties about the Issuer, making proposals to the Issuer concerning changes to the capitalization or operations of the Issuer, purchasing additional Shares, selling some or all of their Shares, engaging in short selling of or any …The first part of Item 4 of the SCHEDULE 13D/A filed 2025-08-22; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-13 | North Run Capital, LP | 9.99% | SCHEDULE 13G/A |
| 2025-08-22 | Pessin Sandra F | 4.7% | SCHEDULE 13D/A |
| 2025-11-13 | North Run Capital, LP | 9.99% | SCHEDULE 13G/A |
| 2025-11-14 | Bleichroeder LP | 21.19% | SCHEDULE 13D/A |
| 2026-08-13 | Lytton Laurence W | 9.99% | SCHEDULE 13G/A |
Tools for this story
Each opens in a new tab, filled in for Scientific Industries Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.